Author: | FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C. | ISBN: | 1230000220417 |
Publisher: | Biopharma Advantage Consulting L.L.C. | Publication: | February 22, 2014 |
Imprint: | Language: | English |
Author: | FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C. |
ISBN: | 1230000220417 |
Publisher: | Biopharma Advantage Consulting L.L.C. |
Publication: | February 22, 2014 |
Imprint: | |
Language: | English |
Good Clinical Practice For Your Reference - Book 4
ICH - Clinical Safety E1 - E2F
ICH-E1 The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-term Treatment of Non-Life-Threatening Conditions
ICH-E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
ICH-E2B(R2) Clinical Safety Data Management : Data Elements for Transmission of Individual Case Safety Reports
ICH-E2C(R1) Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs
ICH-E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting
ICH-E2E Pharmacovigilance Planning
ICH-E2F Development Safety Update Report
Samples of DSURS
European Directive 2001/20/EC
European Directive 2005/28/EC
Good Clinical Practice For Your Reference - Book 4
ICH - Clinical Safety E1 - E2F
ICH-E1 The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-term Treatment of Non-Life-Threatening Conditions
ICH-E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
ICH-E2B(R2) Clinical Safety Data Management : Data Elements for Transmission of Individual Case Safety Reports
ICH-E2C(R1) Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs
ICH-E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting
ICH-E2E Pharmacovigilance Planning
ICH-E2F Development Safety Update Report
Samples of DSURS
European Directive 2001/20/EC
European Directive 2005/28/EC